BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28585395)

  • 1. Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.
    Solheim O; Førsund M; Tropé CG; Kraggerud SM; Nesland JM; Davidson B
    APMIS; 2017 Sep; 125(9):781-786. PubMed ID: 28585395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
    Davidson B; Holth A; Hellesylt E; Tan TZ; Huang RY; Tropé C; Nesland JM; Thiery JP
    Hum Pathol; 2015 Jan; 46(1):1-8. PubMed ID: 25455994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
    Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
    Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
    Yi BR; Kim TH; Kim YS; Choi KC
    Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant ovarian germ cell tumors. Current status of diagnosis and treatment].
    Torres-Lobatón A
    Ginecol Obstet Mex; 2014 Mar; 82(3):177-87. PubMed ID: 24779273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
    Bozhkova DM; Poryazova-Markova EG
    Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.
    Elloul S; Vaksman O; Stavnes HT; Trope CG; Davidson B; Reich R
    Clin Exp Metastasis; 2010 Mar; 27(3):161-72. PubMed ID: 20213325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
    Terashita K; Chuma M; Hatanaka Y; Hatanaka K; Mitsuhashi T; Yokoo H; Ohmura T; Ishizu H; Muraoka S; Nagasaka A; Tsuji T; Yamamoto Y; Kurauchi N; Shimoyama N; Toyoda H; Kumada T; Kaneoka Y; Maeda A; Ogawa K; Natsuizaka M; Kamachi H; Kakisaka T; Kamiyama T; Taketomi A; Matsuno Y; Sakamoto N
    J Clin Pathol; 2016 Jul; 69(7):593-9. PubMed ID: 26670746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
    He N; Wu GF; Zhao HY; Han HX
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
    Bulzico D; Faria PAS; Maia CB; de Paula MP; Torres DC; Ferreira GM; Pires BRB; Hassan R; Abdelhay E; Vaisman M; Vieira Neto L
    Endocrine; 2017 Nov; 58(2):276-288. PubMed ID: 28887601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
    Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression.
    Liu R; Zheng J; Li C; Pang Y; Zheng Q; Xu X; Liu P
    Arch Gynecol Obstet; 2015 Jun; 291(6):1361-9. PubMed ID: 25424898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
    Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
    Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer.
    Adham SA; Al Harrasi I; Al Haddabi I; Al Rashdi A; Al Sinawi S; Al Maniri A; Ba-Omar T; Coomber BL
    J Histochem Cytochem; 2014 Sep; 62(9):619-31. PubMed ID: 24850663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.